NHS Research Scotland supports world-class research in Scotland, fostering collaboration between the NHS, academia, and industry. By providing a streamlined, well-resourced infrastructure and state-of-the-art facilities, it accelerates the development of new medicines, devices, and diagnostics while attracting commercial investment that benefits both the NHS and the wider economy. NHS Research Scotland promotes the value of research in Scotland NHS Research Scotland promotes the value of research in Scotland and supports increased commercial activity being attracted to Scotland, the revenues from which flow back into the NHS and the wider economy.Scotland recognises that to deliver the best quality research and accelerate the development of new medicines, devices and diagnostics, it is essential to draw on the expertise of a number of institutions.This collaborative approach is well regarded in Scotland, and strategic investment in new state-of-the-art locations and facilities, such as Edinburgh BioQuarter, helps bring together NHS, academia and industry under one roof - there are few places in the world where you can actually work with academics from the University and the NHS.Through NHS Research Scotland, a strong infrastructure has been developed that is appealing to industry, delivering Scotland as a single clinical research location with accessible and streamlined approval and contractual processes. Commercial Research Delivery Centre Accelerating access to innovative medicines through clinical trials: Lothian’s CRDC, supported by the UK-wide VPAG initiative, is expanding capacity for high-quality commercial clinical trials, strengthening research infrastructure, building specialised teams, supporting advanced therapies, and bringing innovative treatments to patients faster. Research location capabilities NHS Lothian and the University of Edinburgh offer world-class research facilities and expertise across multiple therapeutic areas. From clinical trials and imaging to patient recruitment and regulatory compliance, our teams deliver high-quality, multidisciplinary research that accelerates access to innovative treatments. This article was published on 2024-11-07
